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 CLINICAL PRESENTATION
A 73-year-old man, with end-stage renal failure 
secondary to ADPKD was transplanted with a 
deceased allograft kidney in 1996.
Between 1996 and 2004, he was immunosup-
pressed with cyclosporine, azathioprine (AZA) and 
prednisone (PDN). In 2004, after the diagnosis of 
squamous-cell carcinoma of the lip, the immunosup-
pression was changed to sirolimus (SRL) and AZA. 
Since 2010, after sepsis with pulmonary origin, he 
was in monotherapy with SRL.  Along these years, 
the serum creatinine increased slightly from 1.2 to 
1.8 mg/dl.
A diagnosis of adenocarcinoma in the right upper 
pulmonary lobe was made, in September 2013, and 
the patient underwent a right upper lobectomy in 
November 2013. The serum creatinine was 1.9 mg/
dl at discharge after surgery. At this time, the siro-
limus was switch to tacrolimus.
An allograft kidney biopsy was done 75 days after 
surgery, due to creatinine increase (1.9 to 3.2 mg/
dl), with a proteinuria of 50 mg/dl. The following 
figures demonstrate the main morphological aspects 
of the biopsy.
 HISTOLOGICAL DIAGNOSIS
The paraffin-embedded fragment shows kidney 
cortical with a total of six glomeruli and several 
medium-sized arteries. The frozen fragment shows 
four glomeruli and the search of C4d in peritubular 
capillaries by immunofluorescence is negative.
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Figure 1 reveals a kidney with profound altera-
tions; an area of interstitial fibrosis with intense 
inflammatory infiltration and tubular atrophy stands 
next to a tubular necrosis area.
Figure 2 presents the acute tubular necrosis area 
in higher magnification; one ischemic glomerulus is 
visible.
In Figure 3, we can see that the acute tubular 
necrosis is very severe; almost all the tubular basal 
membranes are denuded of epithelial tubular cells.
Figure 4 shows two glomeruli with pseudo-cystic 
appearance; the capillaries tufts are severely retracted 
to the vascular pole. The medium-sized artery pres-
ents a reduction of vascular lumen diameter.
In Figure 5, we can see two medium-sized arteries 
with biconvex, needle-shaped clefts. The vascular 
lumens are occluded; the clefts are surrounded by 
fibrous intimal hyperplasia.
In Figure 6, the cleft is surrounded by eosinophilic 
material and fibro-oedematous intimal hyperplasia.
In summary, optical microscopy demonstrates: 3 
globally sclerosed glomeruli in areas of interstitial 
fibrous/tubular atrophy and chronic inflammatory 
infiltrate; occluded medium-sized arteries surrounded 
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by severely ischemic, medium-sized arteries and acute 
tubular necrosis. The histological diagnosis was athe-
roembolic nephropathy.
 COMPLEMENTARY EXAMINATION
Serum analysis reveals a low C3 with normal C4, 
without eosinophilia. 
 DISCUSSION
Atheroembolic disease in kidney allograft is a 
rarely reported disease; between 0.2% and 1% cas-
es1-3 of all biopsies. Until the end of 2012, we report-
ed 0.21% cases of all biopsies4 belonging to two 
patients from our department. In the last year, ath-
eroembolic disease was diagnosis in the first 10 days 
after transplantation (early form) in one patient and 
18 years after transplantation (late form) in this same 
patient.
The late form of the disease in stable allograft 
kidney is usually associated with the same risk fac-
tors and systemic manifestations as the general 
populations. The atherosclerothic plaques are dis-
rupted by direct lesion (angiography or surgery) or 
by drugs (anticoagulant and thrombolytic agents). 
Our patient underwent a major surgical procedure 
and take anticoagulants for prophylaxis of pulmonary 
thromboembolism in the post-operative period. The 
pathognomonic features5 are the biconvex, needle 
shaped clefts. The clefts are the “ghosts” of choles-
terol crystals that are dissolved by the xylol used 
during routine preparation of paraffin-embedded 
biopsy. In this biopsy, we can see an early phase 
of endothelial reaction to cholesterol crystals (Fig. 
6) and a later phase (Fig. 5). The fibrous intimal 
hyperplasia results in arteries occlusion and isch-
aemia of the surrounding tissue.
 CLINICO-ANATOMICAL DIAGNOSIS 
Atheroembolic disease in allograft kidney.
 TREATMENT AND EVOLUTION
The patient was treated with 500 mg IV of methyl-
prednisolone in 3 consecutive days; tacrolimus was 
switched to sirolimus and low-dose aspirin was initiated. 
Serum creatinine rapidly decreased to 1.9 mg/dl.
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